Improved diabetic wound healing through topical silencing of p53 is associated with augmented vasculogenic mediators

Wound Repair and Regeneration

Volumn 18, Issue 6, 2010, Pages 553-559

  Nguyen, Phuong D ^a   Tutela, John Paul ^a   Thanik, Vishal D ^a   Knobel, Denis ^a   Allen Jr , Robert J ^a   Chang, Christopher C ^a   Levine, Jamie P ^a   Warren, Stephen M ^a   Saadeh, Pierre B ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; CYTOKINE; PROTEIN P53; PROTEIN P53 SMALL INTERFERING RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANALYSIS OF VARIANCE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE SILENCING; GENE TARGETING; GENE THERAPY; HISTOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PHOTOMETRY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STUDENT T TEST; UPREGULATION; WESTERN BLOTTING; WOUND CLOSURE; WOUND HEALING; WOUND HEALING IMPAIRMENT;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIGENS, CD31; BLOTTING, WESTERN; CHEMOKINE CXCL12; ENDOTHELIUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; GELS; GENE SILENCING; GENE THERAPY; HYPOXIA-INDUCIBLE FACTOR 1; IMMUNOHISTOCHEMISTRY; MICE; MODELS, ANIMAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SKIN; STAINING AND LABELING; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 78349264256     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2010.00638.x     Document Type: Article

References (34)

1. Botusan IR, Sunkari VG, Savu O, Catrina AI, Grunler J, Lindberg S, Pereira T, Yla-Herttuala S, Poellinger L, Brismar K, Catrina SB., Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice. Proc Natl Acad Sci USA 2008; 105: 19426-31.
2. Catrina SB, Okamoto K, Pereira T, Brismar K, Poellinger L., Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function. Diabetes 2004; 53: 3226-32.
3. Goova MT, Li J, Kislinger T, Qu W, Lu Y, Bucciarelli LG, Nowygrod S, Wolf BM, Caliste X, Yan SF, Stern DM, Schmidt AM., Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol 2001; 159: 513-25.
4. Wetzler C, Kampfer H, Stallmeyer B, Pfeilschifter J, Frank S., Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 2000; 115: 245-53.
5. Callaghan MJ, Ceradini DJ, Gurtner GC., Hyperglycemia-induced reactive oxygen species and impaired endothelial progenitor cell function. Antioxid Redox Signal 2005; 7: 1476-82.
6. Ceradini DJ, Yao D, Grogan RH, Callaghan MJ, Edelstein D, Brownlee M, Gurtner GC., Decreasing intracellular superoxide corrects defective ischemia-induced new vessel formation in diabetic mice. J Biol Chem 2008; 283: 10930-8.
7. Capla JM, Grogan RH, Callaghan MJ, Galiano RD, Tepper OM, Ceradini DJ, Gurtner GC., Diabetes impairs endothelial progenitor cell-mediated blood vessel formation in response to hypoxia. Plast Reconstr Surg 2007; 119: 59-70.
8. Jazayeri L, Callaghan MJ, Grogan RH, Hamou CD, Thanik V, Ingraham CR, Capell BC, Pelo CR, Gurtner GC., Diabetes increases p53-mediated apoptosis following ischemia. Plast Reconstr Surg 2008; 121: 1135-43.
9. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999; 15: 551-78.
10. Lane DP., Cancer.p53, guardian of the genome. Nature 1992; 358: 15-6.
11. Kane CD, Greenhalgh DG., Expression and localization of p53 and bcl-2 in healing wounds in diabetic and nondiabetic mice. Wound Repair Regen 2000; 8: 45-58.
12. Keim AL, Chi MM, Moley KH., Hyperglycemia-induced apoptotic cell death in the mouse blastocyst is dependent on expression of p53. Mol Reprod Dev 2001; 60: 214-24.
13. Ortega-Camarillo C, Guzman-Grenfell AM, Garcia-Macedo R, Rosales-Torres AM, Avalos-Rodriguez A, Duran-Reyes G, Medina-Navarro R, Cruz M, Diaz-Flores M, Kumate J., Hyperglycemia induces apoptosis and p53 mobilization to mitochondria in RINm5F cells. Mol Cell Biochem 2006; 281: 163-71.
14. Schmid T, Zhou J, Brune B., HIF-1 and p53: communication of transcription factors under hypoxia. J Cell Mol Med 2004; 8: 423-31.
15. Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, Zeng Q, Dillehay LE, Madan A, Semenza GL, Bedi A., Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev 2000; 14: 34-44.
16. Waltenberger J., Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res 2001; 49: 554-60.
17. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM., Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221-8.
18. Urbich C, Dimmeler S., Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004; 95: 343-5.
19. Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F, Menegolo M, De Kreutzenberg SV, Tiengo A, Agostini C, Avogaro A., Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005; 45: 1449-57.
20. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC., Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 1 2004; 10: 858-64.
21. Galiano RD, Michaels J, Dobryansky M, Levine JP, Gurtner GC., Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen 2004; 12: 485-92.
22. Michaels J, Churgin SS, Blechman KM, Greives MR, Aarabi S, Galiano RD, Gurtner GC., db/db mice exhibit severe wound-healing impairments compared with other murine diabetic strains in a silicone-splinted excisional wound model. Wound Repair Regen 2007; 15: 665-70.
23. Thanik VD, Greives MR, Lerman OZ, Seiser N, Dec W, Chang CC, Warren SM, Levine JP, Saadeh PB., Topical matrix-based siRNA silences local gene expression in a murine wound model. Gene Ther 2007; 14: 1305-8.
24. Hammond EM, Giaccia AJ., The role of p53 in hypoxia-induced apoptosis. Biochem Biophys Res Commun 2005; 331: 718-25.
25. Greijer AE, Van Der Wall E., The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol 2004; 57: 1009-14.
26. Fels DR, Koumenis C., HIF-1alpha and p53: the ODD couple. Trends Biochem Sci 2005; 30: 426-9.
27. Blagosklonny MV, An WG, Romanova LY, Trepel J, Fojo T, Neckers L., p53 inhibits hypoxia-inducible factor-stimulated transcription. J Biol Chem 1998; 273: 11995-8.
28. Schmid T, Zhou J, Kohl R, Brune B., p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1). Biochem J 2004; 380: 289-95.
29. Hansson LO, Friedler A, Freund S, Rudiger S, Fersht AR., Two sequence motifs from HIF-1alpha bind to the DNA-binding site of p53. Proc Natl Acad Sci USA 2002; 99: 10305-9.
30. Chen D, Li M, Luo J, Gu W., Direct interactions between HIF-1 alpha and Mdm2 modulate p53 function. J Biol Chem 2003; 278: 13595-8.
31. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL., Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996; 16: 4604-13.
32. Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG, Werner S., Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 2 1995; 70: 12607-13.
33. Lerman OZ, Galiano RD, Armour M, Levine JP, Gurtner GC., Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol 2003; 162: 303-12.
34. Drake CJ, LaRue A, Ferrara N, Little CD., VEGF regulates cell behavior during vasculogenesis. Dev Biol 2000; 224: 178-8.